Terms: = Endocrine gland cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Treatment
40 results:
1. Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses.
Guo Y; Li S; Li C; Wang L; Ning W
Front Immunol; 2023; 14():1326018. PubMed ID: 38143770
[TBL] [Abstract] [Full Text] [Related]
2. RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract] [Full Text] [Related]
3. Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas cancer via Crosstalk with AKT Signaling.
Li D; Miermont AM; Sable R; Quadri HS; Mathews Griner LA; Martin SE; Odzorig T; De S; Ferrer M; Powers AS; Hewitt SM; Rudloff U
Mol Cancer Res; 2023 Apr; 21(4):316-331. PubMed ID: 36790955
[TBL] [Abstract] [Full Text] [Related]
4. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
5. miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting foxo1.
Han C; Mo K; Jiang L; Wang K; Teng L
Mol Cell Biochem; 2022 Apr; 477(4):1195-1206. PubMed ID: 35084673
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of c-Myc using 10058-F4 induces anti-tumor effects in ovarian cancer cells via regulation of FOXO target genes.
Ghaffarnia R; Nasrollahzadeh A; Bashash D; Nasrollahzadeh N; Mousavi SA; Ghaffari SH
Eur J Pharmacol; 2021 Oct; 908():174345. PubMed ID: 34270986
[TBL] [Abstract] [Full Text] [Related]
7. Role of FOXO protein's abnormal activation through PI3K/AKT pathway in platinum resistance of ovarian cancer.
Shi YY; Meng XT; Xu YN; Tian XJ
J Obstet Gynaecol Res; 2021 Jun; 47(6):1946-1957. PubMed ID: 33827148
[TBL] [Abstract] [Full Text] [Related]
8. foxo1 mitigates the SMAD3/FOXL2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract] [Full Text] [Related]
9. Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line.
Nozhat Z; Zarkesh M; Baldini E; Mohammadi-Yeganeh S; Azizi F; Hedayati M
Anticancer Agents Med Chem; 2022; 22(4):713-720. PubMed ID: 33461474
[TBL] [Abstract] [Full Text] [Related]
10. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer.
Gong G; Lin T; Yuan Y
J Ovarian Res; 2020 Mar; 13(1):30. PubMed ID: 32192517
[TBL] [Abstract] [Full Text] [Related]
11. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
Sun Y; Peng YB; Ye LL; Ma LX; Zou MY; Cheng ZG
Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462
[TBL] [Abstract] [Full Text] [Related]
12. Identification of Potential Biomarkers with Diagnostic Value in Pituitary Adenomas Using Prediction Analysis for Microarrays Method.
Peng H; Deng Y; Wang L; Cheng Y; Xu Y; Liao J; Wu H
J Mol Neurosci; 2019 Nov; 69(3):399-410. PubMed ID: 31280474
[TBL] [Abstract] [Full Text] [Related]
13. Effects of metformin on the PI3K/AKT/foxo1 pathway in anaplastic thyroid cancer cell lines.
Nozhat Z; Mohammadi-Yeganeh S; Azizi F; Zarkesh M; Hedayati M
Daru; 2018 Dec; 26(2):93-103. PubMed ID: 30242671
[TBL] [Abstract] [Full Text] [Related]
14. Integrated microarray meta-analysis identifies miRNA-27a as an oncogene in ovarian cancer by inhibiting foxo1.
Wang Z; Ji G; Wu Q; Feng S; Zhao Y; Cao Z; Tao C
Life Sci; 2018 Oct; 210():263-270. PubMed ID: 30138596
[TBL] [Abstract] [Full Text] [Related]
15. Propofol Prevents the Progression of Malignant Pheochromocytoma In Vitro and In Vivo.
Wang H; Zhang S; Zhang A; Yan C
DNA Cell Biol; 2018 Apr; 37(4):308-315. PubMed ID: 29565198
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract] [Full Text] [Related]
17. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
Zhang N; Qiu J; Zheng T; Zhang X; Hua K; Zhang Y
Oncol Rep; 2018 Mar; 39(3):1034-1042. PubMed ID: 29286125
[TBL] [Abstract] [Full Text] [Related]
18. CAR T Cells Releasing IL-18 Convert to T-Bet
Chmielewski M; Abken H
Cell Rep; 2017 Dec; 21(11):3205-3219. PubMed ID: 29241547
[TBL] [Abstract] [Full Text] [Related]
19. FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models.
Corno C; Stucchi S; De Cesare M; Carenini N; Stamatakos S; Ciusani E; Minoli L; Scanziani E; Argueta C; Landesman Y; Zaffaroni N; Gatti L; Perego P
Biochem Pharmacol; 2018 Jan; 147():93-103. PubMed ID: 29155058
[TBL] [Abstract] [Full Text] [Related]
20. Britannin induces apoptosis through AKT-foxo1 pathway in human pancreatic cancer cells.
Moeinifard M; Hassan ZM; Fallahian F; Hamzeloo-Moghadam M; Taghikhani M
Biomed Pharmacother; 2017 Oct; 94():1101-1110. PubMed ID: 28821161
[TBL] [Abstract] [Full Text] [Related]
[Next]